OncologyEducation presents MedOncNow – Lyssna här

MedOncNow E02: 2L Treatment of EGFR-Positive NSCLC
18 feb· OncologyEducation presents MedOncNow
Practically Speaking: Mariposa-2. In this episode of MedOncNow, Dr. Barb Melosky joins Dr. Kassam to discuss the use of Amivantimab + Carboplatin + Pemetrexed in the second-line treatment of EGFR-positive non small cell lung cancer (NSCLC) progressing after Osimertinib.

A timely discussion, given that Johnson & Johnson now has a compassionate access program for this regimen.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
MedOncNow: Practically Speaking: Belzutifan - A Spark of Light for Clear Cell Renal Cell Carcinoma
31 jan· OncologyEducation presents MedOncNow
Dr. Kassam is joined by Dr. Aly-Khan Lalani to discuss the use of Belzutifan in the management of previously treated clear cell renal cell carcinoma. With Belzutifan now available in clinic, listen today for important guidance.
- Lyssna Lyssna igen Fortsätt Lyssnar...
- Lyssna senare Lyssna senare
Saknas det avsnitt?

Klicka här för att uppdatera flödet manuellt.